ID | 蛋白ID | Accession | GN:Name | DE:Name | GeneID |
60652 | CEBPA_RAT | P05554 | Cebpa {ECO:0000312|RGD:2326} | CCAAT/enhancer-binding protein alpha {ECO:0000312|RGD:2326}; C/EBP alpha | 24252 |
60651 | CEBPA_MOUSE | P53566; Q91XB6 | Cebpa {ECO:0000312|MGI:MGI:99480} | CCAAT/enhancer-binding protein alpha {ECO:0000312|MGI:MGI:99480}; C/EBP alpha {ECO:0000312|MGI:MGI:99480} | 12606 |
60650 | CEBPA_HUMAN | A7LNP2; P49715; P78319; Q05CA4 | CEBPA {ECO:0000312|HGNC:HGNC:1833} | CCAAT/enhancer-binding protein alpha {ECO:0000312|HGNC:HGNC:1833}; C/EBP alpha {ECO:0000312|HGNC:HGNC:1833} | 1050 |
60649 | CEBPA_BOVIN | O02754; Q4PLC3 | CEBPA {ECO:0000250|UniProtKB:P49715} | CCAAT/enhancer-binding protein alpha {ECO:0000250|UniProtKB:P49715}; C/EBP alpha | 0 |
60648 | CEBP2_CAEEL | Q8IG69 | cebp-2 {ECO:0000312|WormBase:C48E7.11} | CCAAT/enhancer-binding protein homolog 2 {ECO:0000303|PubMed:26876169} | 172319 |
60647 | CEBP1_CAEEL | Q18909 | cebp-1 {ECO:0000312|WormBase:D1005.3} | CCAAT/enhancer-binding protein homolog 1 {ECO:0000312|WormBase:D1005.3} | 180481 |
60646 | CEBOS_MOUSE | Q8BTE5 | Cebpzos {ECO:0000312|MGI:MGI:1915804} | Protein CEBPZOS {ECO:0000305} | 68554 |
60645 | CEBOS_HUMAN | A8MTT3; A8MUR5 | CEBPZOS {ECO:0000312|HGNC:HGNC:49288} | Protein CEBPZOS {ECO:0000305}; CEBPZ antisense RNA 1 {ECO:0000312|HGNC:HGNC:49288}; CEBPZ opposite strand {ECO:0000312|HGNC:HGNC:49288} | 100505876 |
60644 | CEBIP_ORYSJ | B7ELL0; Q1ESX3; Q8H8C7 | CEBIP {ECO:0000303|PubMed:16829581} | Chitin elicitor-binding protein {ECO:0000303|PubMed:16829581}; CEBiP {ECO:0000303|PubMed:16829581}; OsCEBiP {ECO:0000303|PubMed:27238968}; Lysin motif-containing protein 1; Os-LYP1 | 0 |
60643 | CEBA_BACAM | P23939 | | Control protein C.BamHI {ECO:0000303|PubMed:12654995}; C.BamHI {ECO:0000303|PubMed:12654995}; BamHI control element {ECO:0000303|PubMed:1901989} | 0 |
60642 | CEA_ECOLX | Q47108 | caa | Colicin-A | 0 |
60641 | CEA_COLES | R9RL27 | CEA {ECO:0000303|Ref.1} | Mannose-specific lectin CEA {ECO:0000305}; Agglutinin CEA {ECO:0000305} | 0 |
60640 | CEA_CITFR | P04480; Q51599 | caa | Colicin-A | 0 |
60639 | CEAV_ECOLX | P22522 | cvaC | Colicin-V; Microcin-V bacteriocin | 0 |
60638 | CEAS_STRCL | Q9LCV9 | ceaS {ECO:0000303|PubMed:10681345} | N(2)-(2-carboxyethyl)arginine synthase {ECO:0000303|PubMed:14623876}; CEA synthetase {ECO:0000303|PubMed:14623876}; CEAS {ECO:0000303|PubMed:14623876}; 2.5.1.66 {ECO:0000269|PubMed:18052280, ECO:0000269|Ref.5} | 61469723 |
60637 | CEAS1_HUMAN | A6NFV2; Q8N7Q2 | CELF2-AS1 | Putative uncharacterized protein CELF2-AS1; CELF2 antisense RNA 1; CELF2 antisense gene protein 1 | 0 |
60636 | CEAN_ECOLX | P08083 | cna | Colicin-N | 0 |
60635 | CEAM_ECOLX | P05820 | cma | Colicin-M | 0 |
60634 | CEAMA_MOUSE | Q61400; Q99LD6; Q9D329 | Ceacam10 | Carcinoembryonic antigen-related cell adhesion molecule 10; CEA-related cell adhesion molecule 10; CEA10; Carcinoembryonic antigen 10 | 26366 |
60633 | CEAM8_HUMAN | O60399; P31997; Q16574 | CEACAM8 | Carcinoembryonic antigen-related cell adhesion molecule 8; CD67 antigen; Carcinoembryonic antigen CGM6; Non-specific cross-reacting antigen NCA-95; CD66b | 1088 |
60632 | CEAM7_HUMAN | A8K848; O15148; O15149; Q0VAC1; Q13983; Q14002; Q9UPJ2 | CEACAM7 {ECO:0000312|HGNC:HGNC:1819} | Carcinoembryonic antigen-related cell adhesion molecule 7 {ECO:0000305}; CEA cell adhesion molecule 7; Carcinoembryonic antigen CGM2 | 1087 |
60631 | CEAM6_HUMAN | P40199; Q13774; Q14920; Q53XP7 | CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6; Non-specific crossreacting antigen; Normal cross-reacting antigen; CD66c | 4680 |
60630 | CEAM5_MOUSE | Q3UKK2 | Ceacam5 | Carcinoembryonic antigen-related cell adhesion molecule 5; Pregnancy-specific glycoprotein 30 | 73250 |
60629 | CEAM5_HUMAN | H9KVA7; P06731 | CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e | 1048 |
60628 | CEAM4_HUMAN | O75871; Q03715; Q7LDZ7 | CEACAM4 | Carcinoembryonic antigen-related cell adhesion molecule 4; CEA cell adhesion molecule 4; Carcinoembryonic antigen CGM7; Non-specific cross-reacting antigen W236 | 1089 |
60627 | CEAM3_RAT | Q63101; Q63111 | Ceacam3 {ECO:0000312|RGD:2333} | Carcinoembryonic antigen-related cell adhesion molecule 3; Carcinoembryonic antigen CGM1 | 0 |
60626 | CEAM3_HUMAN | G5E978; P40198; Q3KPH9 | CEACAM3 | Carcinoembryonic antigen-related cell adhesion molecule 3; Carcinoembryonic antigen CGM1; CD66d | 1084 |
60625 | CEAM2_MOUSE | D0VY57; E9QLI9; I7HDK2; Q61349; Q8R1N5; Q925P2 | Ceacam2 | Carcinoembryonic antigen-related cell adhesion molecule 2; CEA-related cell adhesion molecule 2; Biliary glycoprotein 2; BGP-2 | 26367 |
60624 | CEAM1_RAT | P16573; Q63093 | Ceacam1 {ECO:0000312|RGD:67396} | Carcinoembryonic antigen-related cell adhesion molecule 1 {ECO:0000250|UniProtKB:P13688}; ATP-dependent taurocolate-carrier protein; Cell-CAM 105 {ECO:0000303|PubMed:8504806}; C-CAM 105; Ecto-ATPase {ECO:0000303|PubMed:2527235}; GP110 {ECO:0000303|PubMed:8536699}; pp120; CD66a | 81613 |
60623 | CEAM1_MOUSE | P31809; Q61350; Q61353 | Ceacam1 {ECO:0000312|MGI:MGI:1347245} | Carcinoembryonic antigen-related cell adhesion molecule 1 {ECO:0000250|UniProtKB:P13688}; Biliary glycoprotein 1 {ECO:0000250|UniProtKB:P13688}; BGP-1; Biliary glycoprotein D; MHVR1; Murine hepatitis virus receptor; MHV-R; CD66a | 26365 |
60622 | CEAM1_HUMAN | A6NE38; A8MY49; O60430; P13688; Q069I7; Q13854; Q13857; Q13858; Q13859 | CEACAM1 {ECO:0000312|HGNC:HGNC:1814} | Carcinoembryonic antigen-related cell adhesion molecule 1 {ECO:0000303|Ref.8}; Biliary glycoprotein 1 {ECO:0000303|PubMed:7628460}; BGP-1; CD66a | 634 |
60621 | CEAK_ECOLX | P75615; Q47502 | cka | Colicin-K | 0 |
60620 | CEAD_ECOLX | P17998 | cda | Colicin-D | 0 |
60619 | CEAC_ECOLX | P00645 | ccl | Cloacin; 3.1.-.-; Ribonuclease | 0 |
60618 | CEAB_RAT | Q10753 | | 80 kDa carcinoembryonic antigen-binding protein | 0 |
60617 | CEAB_ECOLX | P05819 | cba | Colicin-B | 0 |
60616 | CEABS_KITSK | E4N7E5 | | (+)-corvol ether B synthase/(+)-corvol ether A synthase ((2E,6E)-farnesyl diphosphate cyclizing) {ECO:0000303|PubMed:25809275}; 4.2.3.163 {ECO:0000269|PubMed:25809275, ECO:0000269|PubMed:27666571}; 4.2.3.171 {ECO:0000269|PubMed:25809275, ECO:0000269|PubMed:27666571}; Terpene synthase {ECO:0000303|PubMed:25809275}; Type I terpene cyclase {ECO:0000303|PubMed:25809275} | 0 |
60615 | CEA9_ECOLX | P09883 | col | Colicin-E9; 3.1.-.- | 0 |
60614 | CEA8_ECOLX | P09882 | col | Colicin-E8; 3.1.-.- | 0 |
60613 | CEA7_ECOLX | Q47112; Q51604 | colE7 | Colicin-E7; 3.1.-.- | 0 |
60612 | CEA6_ECOLX | P17999 | | Colicin-E6; 3.1.-.-; Ribonuclease | 0 |
60611 | CEA5_ECOLX | P18000 | col | Colicin-E5; 3.1.-.- | 0 |
60610 | CEA3_ECOLX | P00646 | ceaC | Colicin-E3; 3.1.-.-; Colicin-E3 A chain; Ribonuclease | 0 |
60609 | CEA2_ECOLX | P04419 | col | Colicin-E2; 3.1.-.- | 0 |
60608 | CEA21_HUMAN | B7WNQ6; O75296; Q3KPI0; Q6UY47; Q96ER7 | CEACAM21 | Carcinoembryonic antigen-related cell adhesion molecule 21 | 90273 |
60607 | CEA20_MOUSE | Q80Y42; Q9D2Z1 | Ceacam20 {ECO:0000303|PubMed:16139472} | Carcinoembryonic antigen-related cell adhesion molecule 20 {ECO:0000303|PubMed:16139472} | 71601 |
60606 | CEA20_HUMAN | A0A087WXE1; A0A087WYH6; A0A087WYM6; A0A087WZX4; A0A087X155; A7LFK7; Q6UY09 | CEACAM20 {ECO:0000312|HGNC:HGNC:24879} | Carcinoembryonic antigen-related cell adhesion molecule 20 {ECO:0000312|HGNC:HGNC:24879} | 125931 |
60605 | CEA1_SHISO | P21178 | cea | Colicin-E1* | 0 |
60604 | CEA1_ECOLX | P02978 | cea | Colicin-E1 | 0 |
60603 | CEA19_HUMAN | Q5XJ15; Q7Z692; Q7Z693 | CEACAM19 | Carcinoembryonic antigen-related cell adhesion molecule 19; Carcinoembryonic antigen-like 1 | 56971 |